Association between serum α-synuclein levels and neurocognitive deficits in patients with obstructive sleep apnea: A case-control study
Sleep Medicine · 2025
DOI: 10.1016/j.sleep.2025.106583 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Sleep Medicine, 2025. Verfasst von Yao Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, alpha-Synuclein, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Obstructive sleep apnea (OSA) is increasingly recognized as a contributor to neurocognitive dysfunction, yet the underlying biological mechanisms remain insufficiently understood. α-Synuclein, a presynaptic protein implicated in neurodegenerative processes, may be involved in OSA-related cognitive impairment, but its peripheral expression and diagnostic utility have not been fully elucidated. METHODS: In this case-control study, 108 untreated OSA patients and 100 age- and sex-matched healthy controls underwent overnight polysomnography and neurocognitive assessments, including the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). Serum α-synuclein levels were measured using ELISA. Logistic and linear regression analyses were conducted to assess associations between α-synuclein levels and cognitive performance, while ROC curve analysis evaluated the biomarker's predictive accuracy. RESULTS: Serum α-synuclein levels were significantly elevated in OSA patients compared to controls (385.62 ± 125.47 pg/mL vs. 215.30 ± 78.65 pg/mL, p < 0.001). Elevated α-synuclein levels were independently associated with cognitive impairment in OSA (adjusted OR = 1.832, 95 % CI: 1.624-1.995, p = 0.013). Linear regression showed a significant inverse relationship between α-synuclein and MMSE scores (β = -0.459, p = 0.005). ROC analysis revealed strong predictive value for cognitive deficits (AUC = 0.892, sensitivity = 84.0 %, specificity = 86.0 %). CONCLUSION: Elevated serum α-synuclein levels are independently associated with neurocognitive impairment in OSA and may serve as a potential biomarker for early detection and risk stratification. Future longitudinal and interventional studies are warranted to validate its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China.
- Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China. Electronic address: zhangjiewen9900@126.com.
Zitieren
APA
Zhou, Y., & Zhang, J. (2025). Association between serum α-synuclein levels and neurocognitive deficits in patients with obstructive sleep apnea: A case-control study. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.106583
Vancouver
Zhou Y, Zhang J. Association between serum α-synuclein levels and neurocognitive deficits in patients with obstructive sleep apnea: A case-control study. Sleep Medicine. 2025. doi:10.1016/j.sleep.2025.106583
BibTeX
@article{Zhou2025,
author = {Zhou, Yao and Zhang, Jiewen},
title = {Association between serum α-synuclein levels and neurocognitive deficits in patients with obstructive sleep apnea: A case-control study},
journal = {Sleep Medicine},
year = {2025},
doi = {10.1016/j.sleep.2025.106583}
}
EUVIMED